Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorHackensack Meridian Health
About this trial
This study examines the effectiveness of the cardiac rehabilitation program for stroke patients. The study will examine if patients with stroke, who receive cardiac rehabilitation in addition to their standard of care treatments, demonstrate improved recovery of function. It will also examine if these patients have reduced hospital readmission, reduced rate of recurrent stroke, and mortality.
Eligibility criteria
Qualifiers
18 years or older
Stroke diagnosis (ischemic or hemorrhagic) / radiologic evidence of acute stroke
Medically cleared by a cardiologist for participation in the cardiac rehabilitation program with no contraindications to cardiac rehabilitation per American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) guidelines
Ability to transfer on/off the recumbent bike with or without an assistive device safely, with or without assistance from another person
Disqualifiers
Presence of subarachnoid hemorrhage, intracranial aneurysm, intracranial hemangioma, or arteriovenous malformation
Medical disorders that preclude participation in the study as determined by the Principal Investigator.
Inability to have baseline assessment within 60 days post-stroke diagnosis
Patient considered unable to comply with study requirements
Trial design
Treatments tested in this trial
- Cardiac rehabilitation program
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Hackensack Meridian Health
Lead sponsor
The Cardiovascular Institute of New Jersey at Rutgers Robert Wood Johnson Medical School
Collaborator
Source ClinicalTrials.gov